Skip to NavigationSkip to content

Ex-GSK SVP instated as CMO at PureTech

Published on: 24/02/17

PureTech Health, a cross-disciplinary biopharmaceutical company, announced that it had appointed Atul Pande as the Chief Medical Officer. Pande had previously been serving as a Senior Advisor for the last 10 months at the company and now PureTech have made the move to secure his expertise as CMO.

Pande arrives with a wealth of industry experience, having previously held the role of Senior Vice President at GlaxoSmithKline over a period of nine years and, prior to this, had a operated as Vice President of Neurosciences at Pfizer.

Pande commented on his new role: “I am proud and delighted to join this stellar team and hope to be instrumental in enabling the launch of some of the truly innovative medicines in the PureTech Health pipeline. Having been involved in clinical research and development for more than twenty years, I believe that the PureTech Health approach – which starts with ground-breaking science and signals of human efficacy and stresses safety – has important advantages.”

“We are excited to work more closely with Atul and to have access to his drug development expertise across PureTech Health’s pipeline,” said Daphne Zohar, Chief Executive Officer of PureTech Health. “Atul is a seasoned drug development veteran who will help to shepherd our advancing pipeline through mid- and late-stage clinical trials while ensuring that synergies are leveraged across our platforms.”

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches